Scientists are finding innovative approaches to combat deadly brain cancer

Image credit: Unsplash+.

Glioblastoma is a deadly form of brain cancer with limited treatment options and a high mortality rate.

Two separate EU-funded projects, INSTAGLOW led by FluoGuide and OncoViroMRI led by researchers in Israel and Germany, aim to revolutionize the treatment and monitoring of glioblastoma.

Real-time cancer visualization

FluoGuide, a Danish biotechnology company, has developed a fluorescent chemical dye that can be injected into patients before surgery to attack and illuminate aggressive cancer cells.

The fluorescent dye is activated when the surgeon shines infrared light on the brain tissue, allowing the surgeon to precisely remove the cancer cells.

The technology is based on a specific enzyme, the urokinase-type plasminogen activator receptor (uPAR), which is common in aggressive cancer cells.

By attaching a protein-fluorophore tandem to this enzyme, the dye illuminates the boundary between healthy tissue and cancerous tissue during surgery, helping surgeons with more precise removal.

The dye was tested on 36 patients in Denmark and Sweden and was found to be safe. The next phase of research will include further trials in Europe and the USA

While MRI is a common method for “detecting” brain tumors, it is not sufficient to detect early changes in a tumor.

Dr. Or Perlman and his team have modified MRI to produce better images by relying on other molecules instead of water content.

The new MRI technique will be used in conjunction with oncolytic viruses designed to destroy cancer cells.

This approach allows doctors to map dying cells in the brain and determine the effectiveness of virus treatment.

The biggest challenge now is to accelerate the imaging process using artificial intelligence. The new imaging method was mainly tested on mice. The next steps include testing on human patients.

Both the INSTAGLOW and OncoViroMRI projects have potential applications beyond brain cancer. FluoGuide has successfully tested its dye on 16 lung cancer patients and is also evaluating its use in breast cancer and head and neck cancer.


Given that thousands of people die from glioblastoma every year, these innovative approaches offer a glimmer of hope.

While both are in different stages of research and clinical trials, the promising results so far bode well for future treatment options.

If you care about cancer, please read the studies on “Do Peanuts Play Sneaky Tricks in Spreading Cancer?” and Findings from New Trick Knocks Out Tough Guy Prostate Cancer.

For more on cancer, check out recent studies on new ways to extend the lifespan of cancer survivors, as well as results showing new ways to boost cancer-fighting T cells.

follow us on Twitter for more articles on this topic.

Copyright © 2023 Knowridge Science Report. All rights reserved.

Laura Coffey

Laura Coffey is a Worldtimetodays U.S. News Reporter based in Canada. His focus is on U.S. politics and the environment. He has covered climate change extensively, as well as healthcare and crime. Laura Coffey joined Worldtimetodays in 2023 from the Daily Express and previously worked for Chemist and Druggist and the Jewish Chronicle. He is a graduate of Cambridge University. Languages: English. You can get in touch with me by emailing:

Related Articles

Back to top button